Health – Dominican Today

Pneumologist warns of virus risks

Santo Domingo.- Respiratory diseases that are occurring in the country due to several viruses, including Covid-19, as well as others due to bacteria, tend to cause similar symptoms, such as fever and general malaise, but what modifies the disease are the risk factors that the patient may have.

The intensivist pulmonologist, Emil Jorge Manzur, said there are mild cases, and his main recommendation is that if a patient has a history of respiratory problems and other diseases, he should pay attention to him and not abandon his medication, especially when they present difficulty breathing.

Covid on the rise

“There are three, and be careful if more viruses are spread because we not only have Covid, which is already three weeks in the rise of cases; we have influenza, metaneumovirus, we have adenovirus, which are very frequent at this time, among others, without counting the bacterial infections that we commonly see,” expressed the respiratory tract specialist.

He explained that almost all these infections are symptomatic, and these symptoms must be treated.

“The patient should be concerned” whether or not they have difficulty breathing or if the symptoms last more than five days because there are specific things that can be done for each of these viruses or bacterial infections that could modify the disease,” added Jorge Manzur.

Do not self-medicate with antibiotics

Faced with the fact that many people say they are using the same medications prescribed to them when they tested positive for Covid-19 on previous occasions, the specialist does not rule it out completely, although without self-medicating with antibiotics.

He said most people used antiallergic and mucolytic and may do so now, as well as some expectorant syrups.

“What is wrong in the case is that they add antibiotic without knowing if it is bacterial, it is wrong that they use Ivermectin, because they are not used in any context” and other drugs they used in the first line.

As for vitamin and mineral supplements (such as vitamin D, zinc, melatonin, and others) indicated when Covid was at its highest peak, the physician understands that it is not wrong to use them either. However, there is nothing to prove that the impact of the disease will be less.

Avoiding contracting viruses collectively

The renowned pulmonologist calls to take care of oneself within the framework of the possible, to value avoiding exaggerated conglomerations of people without mask protection; if you have a respiratory symptom, you must protect “your neighbor” and use a mask.

“Again, it is a very individual issue because what we do not want is that everyone gets it at the same time,” indicated Jorge Manzur, who added that most people will contract one of these viruses, but we must take care of the most sensitive ones, to avoid a severe impact.

Do not be afraid

“We do not recommend that everyone should be afraid, but we must be aware that the problem is individual. Whether it is bad for you or not is your own problem,” the pulmonologist pointed out.

Dr. Jorge Manzur said that for Covid-19, there are currently some drugs, but he acknowledged that they are expensive, one of which costs more than 30,000 pesos.

1 year 9 months ago

Health, Local

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Dr Abhijit H Joshi takes charge as vice-chancellor of Desh Bhagat University

Chandigarh: Dr Abhijit H Joshi has been appointed as the vice-chancellor of Desh Bhagat University, Mandi Gobindgarh. Dr Joshi has been working as the dean of the faculty of Ayurveda and professor, and head of the Department of Ayurveda and Yoga, Tilak Maharashtra Vidyapeeth, Pune.

Desh Bhagat University welcomes the doctor and stated, "We are delighted to introduce Prof. (Dr.) Abhijit H Joshi as the new Vice Chancellor of DBU. With his extensive experience and expertise, Prof. Joshi brings a fresh perspective and innovative ideas that will propel our university to greater heights of excellence. As the new VC, Prof. (Dr) Abhijit H Joshi is committed to providing quality education, fostering research, and nurturing the holistic growth of our students. His leadership will guide us on an exciting journey of growth and development. Welcome, Prof. (Dr.) Abhijit H Joshi, to Desh Bhagat University! Let's inspire, innovate, and make a difference!."

Also Read: PGIMER appoints Prof Dr Naresh Panda as new Dean Academics

Prof. (Dr.) Abhijit Joshi started his education at the Jilha Parishad School in Shirala, the rural region of Sangli District. He has done his BAMS and M.A. (Sanskrit) from Shivaji University Kolhapur. He acquired his M.D. in Ayurveda from Pune Vidyapeeth and his PhD from Tilak Maharashtra Vidyapeeth, Pune. He has been awarded D.Litt. by Karnataka Sanskrit University, Bengaluru, Yoga Samskutham University, Boston, USA, Charisma University, British West Indies and Lincoln University, Malaysia. He received his Post Doctoral Diploma from Harvard University (Executive Global Systems), Boston, USA.

Prof. (Dr) Abhijit Joshi has about 20 years of professional experience which includes teaching, research, administration, and institution building. He is a popular professor famous for his extremely logical and practical approach towards the most difficult situations. He has dedicated himself for the development of the Department of Ayurveda of Tilak Maharashtra Vidyapeeth and is the backbone of the Vidyapeeth.

He is an academician at par and teaching is his passion. He started his teaching career in the year 2001 as a Lecturer in a college in a rural area of Maharashtra and subsequently assumed position of the Vice Principal in the same college. Currently, he is a Dean of the Faculty of Ayurved and Professor and HoD of the Department of Ayurved and Yoga, Tilak Maharashtra Vidyapeeth, Pune. He has been very instrumental throughout his academic career and has contributed to the expansion of the Institutions he worked in.

Prof. (Dr) Abhijit Joshi is actively involved in many important quality initiatives undertaken by NAAC, Bangalore for quality higher education and is a Member of the NAAC Peer Team since 2017. He is also associated with many Government and Non-Government, National, and International Bodies as an Expert on various committees.

His incessant contribution to research and innovation has brought him many accolades. He has carved a niche in the area of literature research, Ayurveda literature, in particular. Currently, he has various research projects at his disposal, in the field of Ayurved and Sankrit. Some significant milestones of his journey are the conferment of a Presidential Award, i.e. Maharshi Badrayan Vyas Samman – 2019 for his contribution for the cause of Sanskrit Language, Dr Sarvepalli Radhakrishnan National Award, Pride of India Honor, Aryabhatta Award, Gold Medal from European Ayurved Academy for M.D. Research, C.P.D. International Award from the College of Ayurved U.K. (London), International Rugved Vaidyak Bhushan Award from International Ayurveda Association & European Ayurveda Academy, National Award for outstanding contribution in the field of Ayurvedic Research by Siddhapeeth, Pune and so on.

Also Read:Bond fee for MBBS admissions at AFMC Pune increased from 61 lakh to 65 lakh

1 year 9 months ago

State News,News,Health news,Chandigarh,Doctor News,Latest Health News,JB Next

KFF Health News

Idaho Drops Panel Investigating Pregnancy-Related Deaths as US Maternal Mortality Surges

On July 1, Idaho became the only state without a legal requirement or specialized committee to review maternal deaths related to pregnancy.

The change comes after state lawmakers, in the midst of a national upsurge in maternal deaths, decided not to extend a sunset date for the panel set in 2019, when they established the state’s Maternal Mortality Review Committee, or MMRC.

On July 1, Idaho became the only state without a legal requirement or specialized committee to review maternal deaths related to pregnancy.

The change comes after state lawmakers, in the midst of a national upsurge in maternal deaths, decided not to extend a sunset date for the panel set in 2019, when they established the state’s Maternal Mortality Review Committee, or MMRC.

The committee was composed of a family medicine physician, an OB-GYN, a midwife, a coroner, and a social worker, in addition to others who track deaths in Idaho that occur from pregnancy-related complications. Wyoming studies its maternal deaths through a shared committee with Utah. All other states, as well as Washington, D.C., New York City, Philadelphia, and Puerto Rico, have an MMRC, according to the Guttmacher Institute, a reproductive rights research group.

A majority of the state committees were established within the past decade as federal officials scrambled to understand state and local data to address gaps in maternal care. The committees review deaths that occur within a year of pregnancy and identify trends, share findings, and suggest policy changes.

Liz Woodruff, executive director of the Idaho Academy of Family Physicians, said she was “incredibly disappointed” by the legislature’s decision to scuttle the committee. “It seems relevant that the state of Idaho supports a committee that works toward preventing the deaths of pregnant women,” she said. “This should be easy.”

The committee disbanded despite a high rate of maternal mortality in the United States that exceeds those of other high-income countries. The U.S. recorded 23.8 maternal deaths per 100,000 live births in 2020, compared with 8.4 in Canada and 3.6 in Germany, according to the Organization for Economic Cooperation and Development and the Centers for Disease Control and Prevention.

And the U.S. rate is sharply rising. In March, a few weeks before Idaho lawmakers adjourned their 2023 session, the CDC released data that showed the maternal mortality rate in the U.S. climbed in 2021 to 32.9 deaths per 100,000 live births.

Idaho has a particularly acute problem. Its pregnancy-related mortality ratio was 41.8 pregnancy-related deaths per 100,000 live births in 2020, according to the Maternal Mortality Review Committee report from that year.

Hillarie Hagen of Idaho Voices for Children, a nonprofit focused on low- and moderate-income families, said that the committee used the Idaho-specific data to do deep-dive analyses and that an information void would be left by shuttering the board.

“How do we make decisions and policy decisions to improve the health of mothers and their babies if we’re not tracking the data?” she asked. “From our perspective, having consistent data and trends shown over time helps make more sound policy decisions.”

The decision to disband the board came as two hospitals that serve rural areas announced they would stop providing services for expectant mothers. One of the hospitals cited trouble recruiting and retaining OB-GYNs after the state last summer enacted one of the strictest abortion bans in the country.

The committee, tasked with investigating deaths both individually and collectively, found that almost half of the maternal deaths in Idaho in 2020 occurred after delivery.

Amelia Huntsberger, an OB-GYN and a member of the committee, noted also that patients covered by Medicaid during pregnancy are overrepresented in maternal death rates, which led the panel to recommend expansion of postpartum Medicaid coverage to 12 months rather than the current 60 days.

Huntsberger made national headlines this year when she announced plans to leave both her job and the state, citing the state’s abortion ban and the move to dissolve the MMRC.

But in their legislative session, Idaho lawmakers decided not to advance a bill that would have embraced the committee’s recommendation to expand postpartum Medicaid coverage.

The legislation creating the review committee included a “sunset clause” to dissolve the committee on July 1, 2023. Following a contentious session of the Health and Welfare Committee of the Idaho House of Representatives in February, House Bill 81, which would have renewed the committee, failed to advance.

Republican state Rep. Dori Healey said she sponsored the bill because of her work as an advanced practice registered nurse when the legislature is out of session. “For me, being in the health care field, I think it’s always important to understand the why behind anything. Why is this happening? What can we do better?” Healey said. “I feel like in health care we can only improve with knowledge.”

Healey said she hadn’t anticipated the strong opposition to the bill. In declining to advance it, lawmakers cited costs of running the panel, although some, like Huntsberger, say its operation was covered by a federal grant.

The MMRC was funded by the federal Title V Maternal and Child Health Block Grant program, aimed at improving the health of mothers, infants, and children. Idaho has received more than $3 million annually in Title V funds in recent years, according to statistics cited by Huntsberger.

The MMRC, whose members say annual operation costs stand at about $15,000, was deemed budget-neutral, running at no cost to the state.

In an interview with KFF Health News, Marco Erickson, vice chair of the Health and Welfare Committee, said Idaho’s Republican Party has been focused on reducing government spending. He said the same maternal data could be adequately culled through epidemiology reports already published by the Department of Health and Welfare.

“Anytime that there is a death of a mother and child, there is value in evaluating why it occurred,” Erickson said. “The whole committee saw the importance but saw there was another way to do it. It wasn’t that they didn’t think it was valuable.”

Erickson, who previously oversaw elements of maternal and child health in his role as a health program manager for Nevada’s Division of Public and Behavioral Health, said that information could become siloed in government, but it was worthwhile to improve existing bodies, rather than creating a committee anew.

“I think it could be covered elsewhere, and if it’s not being done, they need to make a loud voice to cover it in the existing programs,” he said. “We’re happy to sit down together to find a solution that works.”

The lobbying group Idaho Freedom Foundation celebrated the end of the committee, contending it was a “vehicle to promote more government intervention in health care,” and citing the group’s recommendation to extend Medicaid coverage to mothers for 12 months postpartum.

Elke Shaw-Tulloch, public health administrator at the Department of Health and Welfare, said the department would “continue to collect raw data on maternal deaths and gather as much data as possible through limited, existing sources.” But, she said, it will not have the ability to compel reporting on cases or convene committee members to investigate deaths.

“We are currently assessing what actions we can take and working with stakeholders to address solutions moving forward,” she said.

A group to do so has not yet convened since the legislative session ended in April, although stakeholders say they will focus on bringing another bill before the Idaho Legislature to reinstitute the committee in the 2024 session.

Stacy Seyb, a maternal-fetal specialist who grew up in rural western Kansas and chaired the committee until its dissolution, said that supporting medical providers in more rural areas was part of his lifelong mission and that the work won’t necessarily stop.

“We knew once it didn’t get out of committee that ‘Oh, well, we’re sunk,’” Seyb said. “I know one thing we want to do is collect as much information as we can over the year. Whether it will get reviewed or not, I don’t know.”

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

1 year 9 months ago

Medicaid, Race and Health, States, The Health Law, CDC, Disparities, Idaho, Pregnancy, Rural Health

Health & Wellness | Toronto Caribbean Newspaper

Happy Cancer season star family! Welcome home to you!

BY AKUA GARCIA Happy Cancer season star family!  I pray you are all well. We have shifted seasons from the airy season of Gemini into the fresh waters of Cancer. Get the tissue box; you might need it! Cancer is our first water sign of the zodiac. The water element highlights our intuitive insight, our […]

1 year 9 months ago

Spirituality, #LatestPost

News Archives - Healthy Caribbean Coalition

Mobilising for 2025 – A Caribbean Civil Society NCD Forum

Mobilising for 2025 – A Caribbean Civil Society NCD Forum

July 6-7, 2023
Courtyard Marriott Hotel | Bridgetown, Barbados

Background

Mobilising for 2025 – A Caribbean Civil Society NCD Forum

July 6-7, 2023
Courtyard Marriott Hotel | Bridgetown, Barbados

Background

This meeting: Mobilising for 2025 – A Caribbean Civil Society NCD Forum represents a reconvening of face to face meetings of HCC member organisations and partners. The aim of the Forum is to bring together HCC member civil society organisations (CSOs) and key stakeholders to discuss NCD (including Mental, Neurological and Substance Abuse Disorders – MNSDs)[1] prevention and control priorities in the Caribbean as we reflect on where we are including current  progress and challenges and map a path forward to place the region back on track to meet SDG NCD Target 3.4: Noncommunicable diseases and mental health: By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.

Much work is needed as the most recent 2022 NCD Progress Monitor showed the Caribbean was significantly off track across most areas including risk factor interventions (WHO Best Buys and Recommended Interventions) and treatment indicators (management guidelines and drug therapies).  As a result, the NCD-related health and socioeconomic toll on our fragile economies continues to rise as we face the interconnected challenges of, climate change and food insecurity, exacerbated in our Small Island Developing States (SIDS) settings. From June 14-16, high-level officials from across the SIDS will convene in Barbados for the SIDS Ministerial Conference on NCDs and Mental Health where they will unite in their endorsement of what is anticipated to a be a bold action-oriented Political Outcome Document which recognizes the key health and development threats of NCDs, commercial determinants and climate change and presents concrete actions to tackle these threats as a SIDS community through a highly anticipated SIDS NCDs Roadmap.

The diverse array of civil society actors impacted by NCDs – including those representing: all chronic diseases, key groups such as people living with NCDs (PWLNCDs), young people, related lived experiences, climate change, food systems, and academia – have and continue to play a critical role in driving and supporting rights-based, equitable, evidence-informed NCD responses across the region.

The post Mobilising for 2025 – A Caribbean Civil Society NCD Forum appeared first on Healthy Caribbean Coalition.

1 year 9 months ago

Meetings, News, Slider

Health | NOW Grenada

EC$81.23 million Covid-19 related expenditure for 2020–2021

Grenada’s EC$81.23 million Covid-19 related expenditure had the greatest allocation for Transfers and Social Protection, and the least allocation for the Health Sector

1 year 9 months ago

Health, coronavirus, COVID-19, linda straker, who, world health organisation

Healio News

Glaucoma detection key to MIGS success

I am a comprehensive ophthalmologist practicing at the Center for Excellence in Eye Care, a subspecialty ophthalmology group in Miami. Given our location, we see a high proportion of minority patients from the Caribbean.Minorities, overall, experience a higher incidence of visual impairment from glaucoma than non-minorities.

There are many potential reasons for health care disparities among minority populations, including income and language barriers, medication costs and other factors. The Ocular Hypertension Treatment Study showed a correlation between glaucoma and corneal thickness, and

1 year 9 months ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Investigational Three-Month TB Regimen Safe but Ineffective

The first clinical trial of three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavourable outcomes with the investigational course of treatment. AIDS Clinical Trials Group 5362, also known as the CLO-FAST trial, sought to evaluate the safety and efficacy of a three-month clofazimine- and high-dose rifapentine-containing regimen.

Interim data analysis showed that participants taking the investigational regimen experienced ongoing or recurring TB at rates above the study protocol's threshold.

Based on these findings, the study’s independent Data Safety and Monitoring Board (DSMB) recommended closing enrollment and modifying the treatment and follow-up of participants who received the investigational regimen to optimize outcomes. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, accepted the DSMB recommendations. Participants are notified of the findings, and analyses of the study data are ongoing.

The daily regimen evaluated in CLO-FAST consisted of eight weeks of clofazimine (a 300 mg two-week loading dose followed by 100 mg for six weeks), high-dose rifapentine (1200 mg), isoniazid, pyrazinamide and ethambutol (PHZEC), followed by five weeks of clofazimine (100 mg) with rifapentine, isoniazid and pyrazinamide (PHZC). Participants were randomly assigned to receive either the investigational regimen or six-month standard-of-care treatment or to participate in a sub-study focused on the investigational regimen’s pharmacokinetics (i.e., how the body distributes, absorbs, metabolizes and excretes drugs). The trial began enrollment in November 2021 and had enrolled 104 of 185 planned adult participants at sites in Haiti, India, Malawi, South Africa and Zimbabwe at the time of the interim analysis.

While the investigational regimen did not meet study efficacy criteria, the DSMB determined there were no safety concerns with the drugs. In alignment with DSMB recommendations, participants randomized to receive the investigational regimen will complete the full three months of treatment as planned, then take an additional three months of rifampin and isoniazid. Follow-up of participants in the investigational arm will be extended from 65 weeks to 117 weeks. Participants who already completed the investigational regimen will be monitored closely to confirm they remain free of TB and will receive full standard treatment as indicated.

The World Health Organization estimates that 10.6 million people fell ill with TB in 2021, and 1.6 million people died-the first increase in those estimates in more than a decade. The Centers for Disease Control and Prevention estimates that approximately 13 million people in the United States live with latent TB infection. TB bacteria remain alive but inactive-and 8,300 TB cases were reported nationwide in 2022. Identifying shorter TB treatment regimens is crucial for limiting the spread of infection, reducing drug resistance, improving the quality of life for people with TB disease, and reducing demands on health systems worldwide.

The interim results of the CLO-FAST trial do not support advancing this specific regimen for further evaluation, but the study data will provide essential evidence to inform TB science. NIAID continues prioritising research to advance TB treatment, including evaluating new drug combinations to simplify or shorten treatment duration. NIAID and the A5362 study team express deep gratitude to the study sites and participants participating in the CLO-FAST trial.

1 year 9 months ago

Pulmonology,Pulmonology News,Top Medical News

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Bombay HC Directs DY Patil Medical College to return original documents to 3 students

Mumbai: The Bombay High Court bench has recently directed Kolhapur-based DY Patil Medical College to return back the original certificates of three medical students by July 10, 2023.

These documents include the MBBS marksheets of those three students and their degree certificates. All these documents are essential for admission to Postgraduate courses. It was alleged by the students that their documents were being wrongly withheld by their institute.

Further, the HC bench of Justices Gautam Patel and Neela Gokhale slammed the institute for not having representation before the Court despite being issued a notice on June 15.

“It is not just regrettable but a matter of concern that a college believes that no court can compel it to attend or act in a certain manner,’’ the Bombay High Court bench further noted. 

Approaching the High Court bench the petitioner students claimed that their institute was wrongly withholding their original documents when they sought to leave.

Also Read: Madras HC raps govt for withholding certificates of doctors, orders to ensure immediate bond service postings

While considering the matter, the HC bench took note of the fact that back in the year 2018, the State Government of Maharashtra had issued a notification disallowing private medical colleges from demanding compulsory service bonds after the completion of medical studies of their students.

Times of India adds that during the hearing of the case on June 15, the HC considered the submissions by the counsel for the students, and the Counsels for the Centre and University Grants Commission. After noting their submissions, the HC bench observed that even though the college was served with the petition, it did not appear before the Court. In order to ensure that the college had the opportunity to submit its reply and be heard, the HC bench issued another notice and the matter got adjourned by the Court. At that time, the bench had clarified that no further adjournments would be considered if the college stayed away.

However, the college still stayed away during the hearing of the matter on June 28. Taking note of this, the HC observed, "DY Patil College obviously does not think it is necessary to respond to notices issued by the court or to remain present…if the college fails to remain present despite notice it takes the consequences," adding "it will not be permitted to complain that it was not heard."

The Daily adds that the institute has also not issued the original post graduate certificates and marksheets since May 2022. The Counsel for UGC informed that back in the year 2018, it had notified that the colleges recognised by it as universities or deemed universities could not retain original certificates submitted at the time of admission.

Taking note of this, the court noted that it was “wholly unable” to see especially in the face of the UGC directive “how the DY Patil Medical College can conduct itself in this fashion’’. With this observation, the bench directed the college to hand over the original documents to the three petitioner doctors and listed the matter for further hearing on June 17 to ensure compliance.

Also Read: Medical Degree Certificate not Marketable Commodity, cannot be withheld for unfulfilled bond terms: HC

1 year 9 months ago

State News,News,Maharashtra,Medical Education,Medical Colleges News,Medical Courses News,Top Medical Education News

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

NEET: MCC releases list of Centers Allocated Across India For Issuing Disability Certificates to PwD Candidates

Delhi: Medical Counselling Committee (MCC) has released the list of disability certification centres for issuing disability certificates for NEET UG PwD candidates for the academic year 2023-24.

The PwD portal for the generation of PwD certificates by the Designated Disability NEET screening Centers is now open for all candidates who have registered themselves under the PwD quota in NEET-UG(2023) NTA form. The candidates desiring to get a PwD seat through the MCC counselling process may get the disability certificate issued from any one of the designated NEET Disability screening centres (as per the list attached below) through online mode only.

The candidates must visit the designated Disability NEET Screening Centers for physical examination and quantification of their disability and obtain a PwD certificate generated online by the centre. No other certificate except the one generated through the MCC portal online mode will be accepted at the time of admission.

Also Read:DHS Meghalaya Begins Application Process For MBBS, BDS, BHMS, BAMS, BUMS, BSc Nursing Admissions, details

Further, all candidates, irrespective of whether they have qualified NEET UG exam in terms of cut-off percentile, will be able to get the online certificate issued from the designated centres.

The following are the centres for PwD certificates –

1. Vardhman Mahavir Medical College & Safdarjang Hospital (VMMC & SJH), New Delhi

2. All India Institute of Physical Medicine and Rehabilitation (AIIPMR), Mumbai

3. Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata

4. Madras Medical College (MMC), Chennai

5. Grant Government Medical College, J.J. Hospital Compound, Mumbai

6. Goa Medical College, Goa

7. Government Medical College, Thiruvananthapuram, Kerala

8. SMS Medical College, Jaipur

9. Govt. Medical College and Hospital, Sector32, Chandigarh

10. Govt. Medical College, Agartala, State Disability Board, Agartala

11. Institute of Medical Sciences, Banaras Hindu University, Varanasi

12. Ali Yavar Jung National Institute of Speech and Hearing Disabilities, Bandra, Mumbai

13. AIIMS, Nagpur

14. Atal Bihari Vajpayee Institute of Medical Sciences & RML Hospital, New Delhi. (ABVIMS & RMLH)

15. Lady Hardinge Medical College & Associated Hospitals (LHMC), New Delhi

16. All India Institute of Speech and Hearing (AIISH), Mysuru

The details related to each centre are enclosed in the notice below.

To view the notices, click on the links below –

https://medicaldialogues.in/pdf_upload/notice-for-pwd-candidates-with-centers-list-ug-202-213630.pdf

Also Read:208 Seats Available For Sponsored DNB Post MBBS, Post Diploma Courses, NBE releases seat matrix, check out details

1 year 9 months ago

State News,News,Delhi,Medical Education,Medical Admission News,Latest Medical Education News

Health News Today on Fox News

Athletes, lawmakers and health experts unite to promote CPR and AED training

Fewer than 40% of out-of-hospital cardiac arrest patients receive CPR before EMS teams arrive, according to the American Heart Association. Even fewer patients are treated with an automated external defibrillator or AED. 

Fewer than 40% of out-of-hospital cardiac arrest patients receive CPR before EMS teams arrive, according to the American Heart Association. Even fewer patients are treated with an automated external defibrillator or AED. 

New initiatives and partnerships are working to change that, with the goal of doubling the survival rate for heart attacks.

"The idea is to ensure that lifesaving policies are in place at the high school level to make sure that our kids, if they suffer sudden cardiac arrest, have the best possible chances of success," said Jeff Miller, the NFL's executive vice president for health and safety innovation.

The NFL and other professional sports leagues are working with the Red Cross and the American Heart Association to promote their Smart Heart Coalition.

10 DIETARY TIPS TO REDUCE HEART DISEASE AND STROKE RISK, ACCORDING TO THE AMERICAN HEART ASSOCIATION

"With schools being a focal place for gathering in the community, it's really important that we have emergency response plans," said Nancy Brown, the American Heart Association's CEO. 

"We know that although the statistics are true, that older people are more likely to have a cardiac arrest or a cardiovascular event, young people still have these events as well. So we want to be sure that someone is prepared everywhere to save a life."

When Buffalo Bills safety Damar Hamlin collapsed during a live Monday Night Football game about six months ago, his team’s doctors were prepared.

"The people were in place; they were practiced," said Miller. "They had trained their emergency action plan. They knew to take Damar to a level one trauma center when he was evacuated from the field. They had the device there and they knew what to do with it."

HELP DESPERATELY NEEDED: AMERICAN HEART ASSOCIATION LAUNCHES ‘NATION OF LIFESAVERS’ PROGRAM

Miller said the NFL and Hamlin wanted to take advantage of all the attention received from this incident — and encourage everyone to have a response plan.

"We learned a lot and have tried to share a lot," Miller said. "But at the high school level, obviously they don't have the same sort of resources or setup that the NFL does. And so we want to translate some of those learnings alongside the American Heart Association, the American Red Cross and others to make sure that our schools are in the best possible place to help out kids who might need it."

Every year, an estimated 350,000 people experience a heart attack outside the hospital. One in 300 kids has an undetected heart condition.

"There isn't sufficient awareness. Parents, coaches and others should insist upon these very basic, simple, easy-to-enact solutions to what is a thankfully not very common, but at the same time all too common phenomenon," Miller said. 

"Those deaths are simply preventable by these three simple policy adjustments: CPR education, an emergency action plan and the availability of an AED nearby [within] one to three minutes of an athletic contest or practice so the kid can be saved."

Athletes and health officials have also taken the effort to Capitol Hill. Lawmakers have introduced the Access to AEDs Act, which would provide additional funding for schools.

"It’s grants that would enable communities and athletic facilities to get access," Sen. Peter Welch (D-Vermont) said.

Welch said a reaction plan is important, and a quick response helped save his brother’s life.

"My brother was playing basketball and he collapsed. They had, right there at this gym, a defibrillator," Welch said. 

"And 20 years later, John's still playing basketball. So we're really grateful in the Welch family that this community has done it."

TALK THERAPY? AI MAY DETECT ‘EARLIEST SYMPTOMS’ OF DEMENTIA BY ANALYZING SPEECH PATTERNS

Kansas Sen. Roger Marshall is a medical doctor. He believes if more people know where AEDs are located and how to use them, they can help save additional lives.

"The chances of a person surviving this goes up from one out of 10 to three out of 10 if someone's able to start CPR. It probably goes up to seven out of 10 if we have an AED available as well," Marshall said. 

"I'm committed to getting them across the country in the right locations, but also figuring out everyone should have some type of an app downloaded that could show us those locations."

MedStar Health in Washington, D.C., is partnering with professional athletes from the Washington Capitals, Mystics and Wizards to demonstrate how to perform CPR and how to use an AED.

"Getting the athletes on board, with their star power, definitely makes people excited about it," Dr. Alex Koo said. 

When they show "how easy it is without any training, I think people can get really excited about and say, ‘Hey, I can do it as well.'"

MedStar Health hopes the videos make people more comfortable about learning and performing CPR.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"Black communities, as well as Hispanic communities, sometimes don't have as high rates of bystander CPR. And so that's something that we want to highlight, that this is something that's accessible to everybody," Dr. Koo said.

CPR training no longer includes mouth-to-mouth resuscitation. The American Heart Association also says that hands-only CPR can really make a difference.

"We recognized that mouth-to-mouth resuscitation was a barrier for some people in administering CPR," Brown told Fox News. 

"Generally cardiac arrests, if they are witnessed, are generally witnessed by someone who knows the person that might be having the cardiac arrest. So the skill of learning CPR is really important because you might be saving the life of someone you know and love."

The American Heart Association believes that while formal CPR training is important, simple videos and easy-to-learn methods can still help save lives.

"We do intend at the AHA to create a ‘Nation of Lifesavers’ and we encourage everyone to learn CPR," Brown said. "I think that CPR and AED training should be part of everyone's summer safety plan."

You can watch MedStar Health's videos at MedStarHealth.org/CPR. 

If you are interested in getting CPR-certified or learning to use an AED, you can find a class in your area at CPR.heart.org.

1 year 9 months ago

heart-health, buffalo-bills, nfl, nba, washington-wizards, mlb, new-york-yankees, Health, lifestyle

PAHO/WHO | Pan American Health Organization

PAHO Director meets with Brazilian President to discuss public health priorities

PAHO Director meets with Brazilian President to discuss public health priorities

Oscar Reyes

5 Jul 2023

PAHO Director meets with Brazilian President to discuss public health priorities

Oscar Reyes

5 Jul 2023

1 year 9 months ago

Medscape Medical News Headlines

India's Biocon Biologics Launches Biosimilar for Humira in US

India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoid arthritis drug Humira in the United States. Reuters Health Information

India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoid arthritis drug Humira in the United States. Reuters Health Information

1 year 9 months ago

Dermatology, News

Medscape Medical News Headlines

Fresenius Launches Biosimilar Version of AbbVie's Humira

The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling rheumatoid arthritis drug, will be at a 5% discount to Humira's list price. Reuters Health Information

The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling rheumatoid arthritis drug, will be at a 5% discount to Humira's list price. Reuters Health Information

1 year 9 months ago

Rheumatology, News

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Memantine effective for Trichotillomania and skin-picking disorder

Memantine therapy had a reasonably high effectiveness and was well tolerated in individuals with Trichotillomania and skin-picking condition, says an article published in the American Journal of Psychiatry.

Underrecognized and frequently crippling disorders like trichotillomania and skin-picking disorder cause people to pluck or pick at their skin or hair repeatedly, causing obvious hair loss or tissue damage. There are very few evidence-based therapies available for these illnesses as of right now. Jon Grant and crew conducted this study to see if memantine, a glutamate modulator, may reduce hair pulling and skin picking better than a placebo.

In a double-blind study with memantine (dosing range, 10-20 mg/day) or placebo for 8 weeks, 100 persons with trichotillomania or skin-picking disorder (86 women; mean age, 31.4 years [SD=10.2]) were included. Measures of the intensity of the tugging and plucking were used to evaluate the participants. An analysis of the outcomes was done using a linear mixed-effects model. The NIMH Trichotillomania Symptom Severity Scale was amended to include skin picking as the major outcome measure, and treatment-related improvement on this scale represented success.

The key findings of this study were :

Regarding treatment-by-time interactions, memantine therapy was linked to significantly better scores than placebo on the NIMH scale, Sheehan Disability Scale, and Clinical Global Impressions severity scale.

At the study's conclusion, 60.5% of memantine group participants were "much or very much improved," as opposed to 8.3% of placebo group participants (number required to treat=1.9).

The treatment arms did not substantially vary in adverse events.

This study discovered that memantine medication was well tolerated, had a relatively high effectiveness (based on number needed to treat), and reduced hair pulling and skin-picking symptoms statistically significantly more than placebo. It could be advantageous to focus on the glutamate system while treating obsessive behaviors.

Reference:

Grant, J. E., Chesivoir, E., Valle, S., Ehsan, D., & Chamberlain, S. R. (2023). Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder. In American Journal of Psychiatry (Vol. 180, Issue 5, pp. 348–356). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.ajp.20220737

1 year 9 months ago

Psychiatry,Psychiatry News,Top Medical News,JB Next

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Avapritinib effectively reduces indolent systemic mastocytosis severity: NEJM

A new study by Jason Gotlib and team showed that in individuals with indolent systemic mastocytosis (ISM), avapritinib was more effective than a placebo at lowering uncontrolled symptoms and mast-cell load. The findings of this study were published in NEJM Evidence.

The KIT D816V mutation causes the clonal mast-cell illness known as indolent systemic mastocytosis. In order to compare the effectiveness and safety of avapritinib vs placebo in patients with ISM receiving the best supportive care, this research was carried out.

Avapritinib 25 mg once a day (n=141) or placebo (n=71) were given out randomly to patients with moderate to severe ISM (total symptom score [TSS] of 28; scores range from 0 to 110, with higher values indicating more severe symptoms). The 14-day average of the patient-reported severity of 11 symptoms served as the main endpoint for measuring mean change in TSS. Reduced levels of serum tryptase, blood KIT D816V variant allele fraction, TSS (50% and 30%), bone marrow mast cells (50%), and quality-of-life indicators were among the secondary end objectives.

The key findings of this study were:

Avapritinib-treated individuals saw a drop in TSS of 15.6 points (95% CI, 18.6 to 12.6) from baseline to week 24, as opposed to a fall of 9.2 points (13.1 to 5.2) in the placebo group; P = 0.003.

A 50% decrease in blood tryptase level was attained from baseline to Week 24 in 76/141 patients (54%; 45% to 62%) in the avapritinib group as opposed to 0/71 patients in the placebo group; P 0.001.

Avapritinib caused greater edema and alkaline phosphatase elevations than the placebo; nonetheless, there were few cases of therapy termination due to side effects.

Avapritinib exhibited superiority to placebo in treating symptoms in patients with mild to severe symptomatic ISM on BSC during this 24-week blinded phase of the PIONEER study. Overall AE incidence was comparable amongst the groups, and discontinuation rates were low. The current 5-year open-label extension is intended to assess the durability of avapritinib's effectiveness and safety.

Reference:

Gotlib, J., Castells, M., Elberink, H. O., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., Tashi, T., Bulai Livideanu, C., Sabato, V., Reiter, A., Pongdee, T., … Maurer, M. (2023). Avapritinib versus Placebo in Indolent Systemic Mastocytosis. In NEJM Evidence (Vol. 2, Issue 6). Massachusetts Medical Society. https://doi.org/10.1056/evidoa2200339

1 year 9 months ago

Dermatology,Medicine,Dermatology News,Medicine News,Top Medical News

Healio News

Cyltezo launches as first interchangeable Humira biosimilar

Cyltezo, the first interchangeable Humira biosimilar, officially entered the U.S.

market on July 1, opening a floodgate that will see the release this month of half a dozen biosimilars for what has been the top selling drug in the country.Six Humira biosimilars are set to launch in the United States in July, bringing the total number of available adalimumab biosimilar drugs to eight.Among the first of these July releases is Cyltezo (adalimumab-adbm, Boehringer Ingelheim), which has received FDA approval as an interchangeable biosimilar drug to adalimumab (AbbVie, Humira) and has been approved

1 year 9 months ago

Health

A holistic approach to PCOS

Polycystic ovary syndrome (PCOS) is a common condition that affects how a woman’s ovaries operate, in which the ovaries produce an abnormal amount of androgens, or male sex hormones, that are normally present in women in small amounts. PCOS...

Polycystic ovary syndrome (PCOS) is a common condition that affects how a woman’s ovaries operate, in which the ovaries produce an abnormal amount of androgens, or male sex hormones, that are normally present in women in small amounts. PCOS...

1 year 9 months ago

Pages